The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Moderna Inc. (NASDAQ: MRNA) is advancing its vaccine portfolio, with regulatory submissions underway for its seasonal ...

An update from Moderna ( ($MRNA) ) is now available. In a January 5, 2026 letter to shareholders, Moderna reviewed a challenging 2025 operating ...

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS ...

Moderna (MRNA) provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 ...

Influenza has caused 3,100 deaths and 81,000 hospitalizations among 7.5 million flu cases so far this respiratory disease ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

The total number of lives saved since the first vaccines is mindboggling, well over a billion globally and perhaps two ...

The President's efforts to slash the federal government have already impacted millions in the U.S. and around the world.

This is a collection of local news concisely presented to provide a quick overview of what you might otherwise have missed.

Flu cases are climbing across the United States as the season reaches its peak, and millions of people may get sick in the ...

Winter Park Resort reopens gondola after malfunction that stranded 182 passengers Winter Park Resort’s communications team ...